TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting: a Randomised Controlled Trial
Brief Summary: The purpose of this study is to investigate whether a device that allows office workers to sit or stand whilst working can reduce their sitting time at work and improve their health over 8 weeks.


Options:
A: Arm Label: education only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: education talk and leaflet | Arm Label: prompt + education; Type: EXPERIMENTAL; Interventions: Device: MyRestBreak 1.0, Behavioral: education talk and leaflet | Intervention Type: DEVICE; Name: MyRestBreak 1.0; Assigned to Arm(s): prompt + education | Intervention Type: BEHAVIORAL; Name: education talk and leaflet; Assigned to Arm(s): education only, prompt + education
B: Arm Label: High intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Low intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): High intensity intervention group, Low intensity intervention group
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sit-stand workstation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-stand workstation; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting: a Randomised Controlled Trial
Brief Summary: The purpose of this study is to investigate whether a device that allows office workers to sit or stand whilst working can reduce their sitting time at work and improve their health over 8 weeks.


Options:
A: Arm Label: Novel workplace - first half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Novel workplace - second half; Type: EXPERIMENTAL; Interventions: Other: Workplace consisting of two height-adjustable desks | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Workplace consisting of two height-adjustable desks; Assigned to Arm(s): Novel workplace - first half, Novel workplace - second half
B: Arm Label: High intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Low intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): High intensity intervention group, Low intensity intervention group
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sit-stand workstation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-stand workstation; Assigned to Arm(s): Intervention
D: Arm Label: Physical activity treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Pedal@Work | Arm Label: Wait List Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pedal@Work Worksite Wellness | Intervention Type: BEHAVIORAL; Name: Pedal@Work Worksite Wellness; Assigned to Arm(s): Wait List Control | Intervention Type: BEHAVIORAL; Name: Pedal@Work; Assigned to Arm(s): Physical activity treatment group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Mixed-methods Evaluation of Sit-stand Workstations in an Office Setting: a Randomised Controlled Trial
Brief Summary: The purpose of this study is to investigate whether a device that allows office workers to sit or stand whilst working can reduce their sitting time at work and improve their health over 8 weeks.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Sit-stand workstation | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Sit-stand workstation; Assigned to Arm(s): Intervention
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention group | Arm Label: Intervention control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control group | Intervention Type: BEHAVIORAL; Name: Intervention group; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Control group; Assigned to Arm(s): Intervention control
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: educational program, Other: exercise program, Other: Self-led exercises | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: educational program; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: exercise program; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Self-led exercises; Assigned to Arm(s): 1
D: Arm Label: Treadmill workstation; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill workstation, Behavioral: Health talk | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Behavioral: Health talk | Intervention Type: BEHAVIORAL; Name: Treadmill workstation; Assigned to Arm(s): Treadmill workstation | Intervention Type: BEHAVIORAL; Name: Health talk; Assigned to Arm(s): Control group, Treadmill workstation

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Children With Fever and Respiratory Symptoms at Out-of-hours Services in Norway
Brief Summary: Viral self-limiting infections in respiratory organs among children are common in primary care. Serious infections have low prevalence and are challenging to distinguish from self-limiting infections.

Prescription of antibiotics in primary care is still high but stable since 2009 in Norway, and 90% of all antibiotics are prescribed in primary care.

C-reactive protein (CRP) has been especially popular in Norway for point-of-care testing in primary care, but its role in ruling-out serious infections and the cut-off value for prescribing antibiotics has been discussed a lot.

The aim of this study is to identify if pretesting with CRP of all children 0-6 year with fever or respiratory symptoms at Out-of-Hours Services will affect the prescription of antibiotics and the referral to hospital for children.


Options:
A: Intervention Type: OTHER; Name: laboratory value procalcitonin; Assigned to Arm(s): N/A
B: Arm Label: PCT guidance; Type: OTHER; Interventions: Other: the procalcitonin arm | Arm Label: clinical reassessment; Type: OTHER; Interventions: Other: the clinical reassessment arm | Intervention Type: OTHER; Name: the clinical reassessment arm; Assigned to Arm(s): clinical reassessment | Intervention Type: OTHER; Name: the procalcitonin arm; Assigned to Arm(s): PCT guidance
C: Arm Label: Pre-consultation CRP; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Pre-consultation CRP | Arm Label: CRP requested; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pre-consultation CRP; Assigned to Arm(s): Pre-consultation CRP
D: Arm Label: Antibiotic use feedback letter 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Antibiotic use feedback letter | Arm Label: Antibiotic use feedback letter 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Antibiotic use feedback letter | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Antibiotic use feedback letter; Assigned to Arm(s): Antibiotic use feedback letter 1, Antibiotic use feedback letter 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
Brief Summary: A Randomized, Double-blind, Placebo Controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome


Options:
A: Arm Label: Group 1: Experimental; Type: ACTIVE_COMPARATOR; Interventions: Biological: Certolizumab pegol | Arm Label: Group 2: Placebo Comparator; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: BIOLOGICAL; Name: Certolizumab pegol; Assigned to Arm(s): Group 1: Experimental | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 2: Placebo Comparator
B: Arm Label: ASP6294; Type: EXPERIMENTAL; Interventions: Drug: ASP6294 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: ASP6294; Assigned to Arm(s): ASP6294 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: AQX-1125; Type: EXPERIMENTAL; Interventions: Drug: AQX-1125 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AQX-1125; Assigned to Arm(s): AQX-1125 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: PF-04383119 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: PF-04383119; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Glial Regulators for Treating Comorbid Posttraumatic Stress and Substance Abuse Disorders
Brief Summary: Examine the effects of N-acetylcysteine on PTSD symptoms, craving and substance use in veterans with PTSD and comorbid substance use disorders.


Options:
A: Arm Label: Oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Control
B: Arm Label: N-Acetylcysteine; Type: EXPERIMENTAL; Interventions: Drug: N-acetylcysteine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: N-acetylcysteine; Assigned to Arm(s): N-Acetylcysteine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Treatment (Viibryd); Type: EXPERIMENTAL; Interventions: Drug: Treatment (Viibryd) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Treatment (Viibryd) | Intervention Type: DRUG; Name: Treatment (Viibryd); Assigned to Arm(s): Placebo, Treatment (Viibryd)
D: Arm Label: Prazosin Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: prazosin | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: prazosin; Assigned to Arm(s): Prazosin Group | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Placebo Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: rEduction of oXygen After Cardiac arresT (EXACT): a Pilot Study
Brief Summary: This Phase 2 study aims to determine the feasibility of paramedic titration of oxygen delivery in adult patients who have been resuscitated from OHCA.


Options:
A: Arm Label: Oxygenation, rigorous normal; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Oxygen, free conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygenation, rigorous normal
B: Arm Label: Oxygen reduction; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen reduction, Standard Care
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): A, B
D: Arm Label: Post op care; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen delivery, Other: Oxygen administration | Arm Label: Oxygen administration- different %; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen administration | Intervention Type: OTHER; Name: Oxygen delivery; Assigned to Arm(s): Post op care | Intervention Type: OTHER; Name: Oxygen administration; Assigned to Arm(s): Oxygen administration- different %, Post op care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: rEduction of oXygen After Cardiac arresT (EXACT): a Pilot Study
Brief Summary: This Phase 2 study aims to determine the feasibility of paramedic titration of oxygen delivery in adult patients who have been resuscitated from OHCA.


Options:
A: Arm Label: Oxygen reduction; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen reduction, Standard Care
B: Arm Label: Post op care; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen delivery, Other: Oxygen administration | Arm Label: Oxygen administration- different %; Type: ACTIVE_COMPARATOR; Interventions: Other: Oxygen administration | Intervention Type: OTHER; Name: Oxygen delivery; Assigned to Arm(s): Post op care | Intervention Type: OTHER; Name: Oxygen administration; Assigned to Arm(s): Oxygen administration- different %, Post op care
C: Arm Label: Oxygen therapy; Type: OTHER; Interventions: Other: Oxygen therapy | Arm Label: No oxygen therapy; Type: OTHER; Interventions: Other: No oxygen therapy | Intervention Type: OTHER; Name: Oxygen therapy; Assigned to Arm(s): Oxygen therapy | Intervention Type: OTHER; Name: No oxygen therapy; Assigned to Arm(s): No oxygen therapy
D: Arm Label: Oxygenation, rigorous normal; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Oxygen, free conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygenation, rigorous normal

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Proyecto Madrileño Sobre el Manejo de la Enfermedad Pulmonar Obstructiva Crónica Con Telemonitorización a Domicilio. (Multicentre Project on the Home Telemonitoring of Patients With Severe Chronic Obstructive Pulmonary Disease).
Brief Summary: The purpose of the study is to verify the clinical effectiveness of a managed home telemonitoring program in patients with severe COPD against usual clinical practice, as measured by the decrease in the number of exacerbations, number of hospitalizations, hospital days and emergency room visits in a 12 month period

The primary endpoint of effectiveness is "severe exacerbations avoided."

The main hypothesis is that patients with severe or very severe COPD patients managed with a home telehealth program have better outcomes than patients managed according to usual clinical practice.


Options:
A: Arm Label: Telemedicine (TeleRR); Type: EXPERIMENTAL; Interventions: Device: Telemedicine: Maintenance Respiratory Rehabilitation | Arm Label: Clinical Practice (Recommendation); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telemedicine: Maintenance Respiratory Rehabilitation; Assigned to Arm(s): Telemedicine (TeleRR)
B: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised COPD Rehabilitation (control group) | Arm Label: Online COPD rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Online COPD rehabilitation (experimental) | Intervention Type: BEHAVIORAL; Name: Supervised COPD Rehabilitation (control group); Assigned to Arm(s): Control group | Intervention Type: BEHAVIORAL; Name: Online COPD rehabilitation (experimental); Assigned to Arm(s): Online COPD rehabilitation
C: Arm Label: COPD, Telehealth; Type: EXPERIMENTAL; Interventions: Device: Telehealth | Arm Label: COPD, Normal clinical practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telehealth; Assigned to Arm(s): COPD, Telehealth
D: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Proyecto Madrileño Sobre el Manejo de la Enfermedad Pulmonar Obstructiva Crónica Con Telemonitorización a Domicilio. (Multicentre Project on the Home Telemonitoring of Patients With Severe Chronic Obstructive Pulmonary Disease).
Brief Summary: The purpose of the study is to verify the clinical effectiveness of a managed home telemonitoring program in patients with severe COPD against usual clinical practice, as measured by the decrease in the number of exacerbations, number of hospitalizations, hospital days and emergency room visits in a 12 month period

The primary endpoint of effectiveness is "severe exacerbations avoided."

The main hypothesis is that patients with severe or very severe COPD patients managed with a home telehealth program have better outcomes than patients managed according to usual clinical practice.


Options:
A: Arm Label: Urban training Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Urban training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Urban training; Assigned to Arm(s): Urban training Intervention
B: Arm Label: COPD, Telehealth; Type: EXPERIMENTAL; Interventions: Device: Telehealth | Arm Label: COPD, Normal clinical practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telehealth; Assigned to Arm(s): COPD, Telehealth
C: Arm Label: Health Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Health Coaching | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health Coaching; Assigned to Arm(s): Health Coaching
D: Arm Label: Traditional hospital-based PR; Type: ACTIVE_COMPARATOR; Interventions: Other: Hospital-based PR | Arm Label: Web-based PR; Type: EXPERIMENTAL; Interventions: Other: Web-based PR | Intervention Type: OTHER; Name: Web-based PR; Assigned to Arm(s): Web-based PR | Intervention Type: OTHER; Name: Hospital-based PR; Assigned to Arm(s): Traditional hospital-based PR

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Non-invasive Positive Pressure Ventilation for the Treatment of Severe Stable Chronic Obstructive Pulmonary Disease
Brief Summary: Assessment of the effect and safety of noninvasive positive pressure ventilation for severe stable chronic obstructive pulmonary disease


Options:
A: Arm Label: Active Treatment; Type: ACTIVE_COMPARATOR; Interventions: Device: Continuous Positive Airway Pressure (CPAP) Treatment | Arm Label: Sham/Placebo Treatment; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham CPAP device - CPAP device with pressure delivered <1 cm H20 | Intervention Type: DEVICE; Name: Continuous Positive Airway Pressure (CPAP) Treatment; Assigned to Arm(s): Active Treatment | Intervention Type: DEVICE; Name: Sham CPAP device - CPAP device with pressure delivered <1 cm H20; Assigned to Arm(s): Sham/Placebo Treatment
B: Arm Label: LTNIV group; Type: EXPERIMENTAL; Interventions: Device: LTNIV | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: LTNIV; Assigned to Arm(s): LTNIV group
C: Intervention Type: DEVICE; Name: Noninvasive positive pressure ventilation; Assigned to Arm(s): N/A
D: Arm Label: Noninvasive ventilator; Type: EXPERIMENTAL; Interventions: Device: BiPAP mode | Arm Label: LTOT; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: BiPAP mode; Assigned to Arm(s): Noninvasive ventilator

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Non-invasive Positive Pressure Ventilation for the Treatment of Severe Stable Chronic Obstructive Pulmonary Disease
Brief Summary: Assessment of the effect and safety of noninvasive positive pressure ventilation for severe stable chronic obstructive pulmonary disease


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Other: breathing retraining, Other: exercise training | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Other: exercise training | Intervention Type: OTHER; Name: breathing retraining; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: exercise training; Assigned to Arm(s): Arm 1, Arm 2
B: Arm Label: Urban training Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Urban training | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Urban training; Assigned to Arm(s): Urban training Intervention
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Outreach education training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: No outreach education training | Intervention Type: BEHAVIORAL; Name: Outreach education training; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: No outreach education training; Assigned to Arm(s): Control
D: Arm Label: Noninvasive ventilator; Type: EXPERIMENTAL; Interventions: Device: BiPAP mode | Arm Label: LTOT; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: BiPAP mode; Assigned to Arm(s): Noninvasive ventilator

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-blind, Phase 3 Study Evaluating TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Gastric Cancer Refractory to Standard Treatments
Brief Summary: The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer.


Options:
A: Arm Label: Sunitinib; Type: EXPERIMENTAL; Interventions: Drug: Sunitinib | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): Sunitinib | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: TAS-102+BSC; Type: EXPERIMENTAL; Interventions: Drug: TAS-102 | Arm Label: Placebo+BSC; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: TAS-102; Assigned to Arm(s): TAS-102+BSC | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo+BSC
C: Arm Label: A 850; Type: EXPERIMENTAL; Interventions: Drug: apatinib tablet | Arm Label: B 425; Type: EXPERIMENTAL; Interventions: Drug: apatinib tablet | Arm Label: C pla; Type: PLACEBO_COMPARATOR; Interventions: Drug: apatinib tablet | Intervention Type: DRUG; Name: apatinib tablet; Assigned to Arm(s): A 850, B 425, C pla
D: Arm Label: Everolimus + BSC; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Best Supportive Care (BSC) | Arm Label: Placebo + BSC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Everolimus placebo, Drug: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus + BSC | Intervention Type: DRUG; Name: Everolimus placebo; Assigned to Arm(s): Placebo + BSC | Intervention Type: DRUG; Name: Best Supportive Care (BSC); Assigned to Arm(s): Everolimus + BSC, Placebo + BSC

Answer: B